Effects of KATPchannel blockade by glibenclamide on the warm-up phenomenon

Open Access
Publisher Website
Google Scholar
Abstract
Aims The increased tolerance to myocardial ischaemia observed during the second of two sequential exercise tests, i.e. the warm-up phenomenon, has been proposed as a clinical model of ischaemic preconditioning. As ATP-sensitive K+channels appear to be a mediator of ischaemic preconditioning in both experimental and clinical studies, the aim of this study was to investigate the role of KATPchannels in the warm-up phenomenon. Methods and Results Twenty-six patients with coronary artery disease were randomized to receive 10mg oral glibenclamide, a selective ATP-sensitive K+channel blocker, or placebo. Sixty minutes after glibenclamide or placebo administration, patients were given an infusion of 10% dextrose (8ml.min−1) to correct glucose plasma levels or, respectively, an infusion of saline at the same infusion rate. Thirty minutes after the beginning of the infusions, both patient groups underwent two consecutive treadmill exercise tests, with a recovery period of 15min to re-establish baseline conditions. Before exercise tests, blood glucose levels were similar in placebo and glibenclamide groups (96±10 vs 105±22mg.100ml−1,P=ns). After placebo administration, rate-pressure product at 1·5mm ST-segment depression significantly increased during the second exercise test compared to the first (220±41 vs 186±29 beats.min−1.mmHg.102,P−1.mmHg.102,P=ns), with a significant drug-test interaction (P=0·0091, at two-way ANOVA). Conclusions Glibenclamide, at a dose previously shown to abolish ischaemic preconditioning during coronary angioplasty, prevents the increase of ischaemic threshold observed during the second of two sequential exercise tests. These findings confirm that ischaemic preconditioning plays a key role in the warm-up phenomenon and that in this setting is, at least partially, mediated by activation of ATP-sensitive K+channels.

This publication has 0 references indexed in Scilit: